Close Menu

NEW YORK (GenomeWeb) – Singapore-based molecular diagnostics firm Nova Satra today announced a US$2 million investment from Genting Bio Cellular, a wholly owned subsidiary of investment and management firm Genting Berhad.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.